ProductUpdated on 13 March 2025

Atophylline: a bioinspired skin care against atopic dermatitis (AD)

Quoc Tuan Do

Head of Chemoinformatics/Business development at Greenpharma

ORLEANS, France

About

Based on an innovative concept of neutraligand, it acts selectively on chemokine CCL17 to block the vicious circle of AD.

Proven efficiency: Inhibits the chemokine CCL17 and not its receptor Inhibits genes involved in AD Stimulates synthesis of collagen, elastin and hyaluronic acid in normal cells.

Observations on volunteers: Reduces itchy skin, skin inflammation Increases hydration and skin barrier function Improves quality of life.

Organisation

Greenpharma SAS

Company

ORLEANS, France

Similar opportunities